IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q1 2016 Holdings

Filed 2016-04-19 | 18 holdings | $35.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anika Therapeutics Inc(ANIK)COM035255108$21.9M490,33161.5%
Charles RIV Labs Intl Inc(CRL)COM159864107$13.5M178,30738.0%
FEI CoCOM30241L109$21.3K239,6090.1%
Lifepoint Health IncCOM53219L109$19.0K274,4300.1%
GNC Hldgs IncCOM CL A36191G107$18.6K586,9550.1%
Amag Pharmaceuticals Inc(AMAG)COM00163U106$17.3K740,5850.0%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$13.8K903,5330.0%
Taro Pharmaceutical Inds LTDSHSM8737E108$13.5K94,0050.0%
Inc Resh Hldgs IncCL A45329R109$13.4K324,2700.0%
Merck & Co Inc New(MRK)COM58933Y105$13.3K251,4000.0%
Anthem Inc(ELV)COM036752103$13.1K93,9000.0%
Triple-S Mgmt Corp(GTS)CL B896749108$12.5K503,8260.0%
Valeant Pharmaceuticals IntlCOM91911K102$9.7K370,0000.0%
Symmetry Surgical IncCOM87159G100$3.1K316,4270.0%
Orasure Technologies Inc(OSUR)COM68554V108$2.9K405,7710.0%
Depomed IncCOM249908104$2.8K200,0000.0%
Sciclone Pharmaceuticals IncCOM80862K104$2.6K236,2880.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$1.2K168,3230.0%